By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Feb 2, 2014/Test & Measure
Measures strength and power of the gastrocnemius, soleus, and Achilles tendon complex; part of a test battery shown to be reliable and valid for evaluation of lower leg function in patients with Achilles tendinopathy.
May 21, 2017/Test & Measure
The measure can be used as an outcome measure in clinical practice or research, or to aid clinicians in making decisions regarding patient care.
Aug 31, 2017/Test & Measure
Measures the head thrust test is used to identify individuals with hypofunction of the vestibulo-ocular reflex unilaterally and bilaterally.
Nov 1, 2022/Column
It's fitting that the APTA Honors & Awards Ceremony now recognizes recipients during the APTA Leadership Congress.
Nov 1, 2023/Feature
See the 2023 class of Catherine Worthingham Fellows, Emerging Leaders, and Outstanding Students.
Jun 11, 2017/Clinical Summary
CGH is a condition in which pain is referred to the head and/or face from the cervical spine.
Apr 23, 2021/Statement
Statement by the APTA Board of Directors.
Nov 18, 2025/Article
The U.S. Centers for Medicare & Medicaid Services finalized a 3.26% increase to the conversion factor in the final Medicare Part B Physician Fee Schedule for 2026, resulting in physical therapists, on average, receiving a 1.75% increase in reimbursement under the fee schedule. What You Need to Know Reflecting
Nov 1, 2019/Column
Thoughts on a presidential address.
Aug 15, 2025/Article
Fact Sheet: Quality Payment Program Proposals The U.S. Centers for Medicare & Medicaid Services has released the proposed 2026 Medicare Part B Physician Fee Schedule. In Part 1 of our recap, we covered the conversion factor increase, devaluation of PT codes, and the agency’s interest in prevention and